{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:52:44Z","timestamp":1780638764507,"version":"3.54.1"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Weifang Science and Technology Development Plan Project","award":["No. 2024YX039"],"award-info":[{"award-number":["No. 2024YX039"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No.ZR2020MH202"],"award-info":[{"award-number":["No.ZR2020MH202"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.32000495"],"award-info":[{"award-number":["No.32000495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01757-0","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T03:05:56Z","timestamp":1764212756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-coding RNAs-regulated SLC7A11 modulates ferroptosis: a new strategy for cancer therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Xinyu","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"1757_CR1","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.bbamcr.2012.05.010","volume":"1823","author":"CP Anderson","year":"2012","unstructured":"Anderson CP, Shen M, Eisenstein RS, Leibold EA (2012) Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta 1823:1468\u20131483. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.05.010","journal-title":"Biochim Biophys Acta"},{"key":"1757_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.37796\/2211-8039.1445","volume":"14","author":"J Anthony","year":"2024","unstructured":"Anthony J, Varalakshmi S, Sekar AK, Devarajan N, Janakiraman B, Peramaiyan R (2024) Glutaminase - a potential target for cancer treatment. BioMedicine 14:29\u201337. https:\/\/doi.org\/10.37796\/2211-8039.1445","journal-title":"BioMedicine"},{"key":"1757_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108233","volume":"255","author":"N Bedolla","year":"2025","unstructured":"Bedolla N, Liu L, Liu X, Xie Q, Ren Y (2025) Ursolic acid enhances radiosensitivity in esophageal squamous cell carcinoma by modulating p53\/SLC7A11\/GPX4 pathway-mediated ferroptosis. Toxicon 255:108233. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108233","journal-title":"Toxicon"},{"key":"1757_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.omtn.2022.03.020","volume":"28","author":"G Bi","year":"2022","unstructured":"Bi G, Liang J, Zhao M, Zhang H, Jin X, Lu T, Zheng Y, Bian Y, Chen Z, Huang Y, Besskaya V, Zhan C, Wang Q, Tan L (2022) MiR-6077 promotes cisplatin\/pemetrexed resistance in lung adenocarcinoma via CDKN1A\/cell cycle arrest and KEAP1\/ferroptosis pathways. Mol Ther 28:366\u2013386. https:\/\/doi.org\/10.1016\/j.omtn.2022.03.020","journal-title":"Mol Ther"},{"key":"1757_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020423","author":"Z Bian","year":"2023","unstructured":"Bian Z, Sun X, Liu L, Qin Y, Zhang Q, Liu H, Mao L, Sun S (2023) Sodium butyrate induces CRC cell ferroptosis via the CD44\/SLC7A11 pathway and exhibits a synergistic therapeutic effect with Erastin. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15020423","journal-title":"Cancers (Basel)"},{"key":"1757_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-94-017-9211-0_18","volume":"85","author":"AV Budanov","year":"2014","unstructured":"Budanov AV (2014) The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem 85:337\u2013358. https:\/\/doi.org\/10.1007\/978-94-017-9211-0_18","journal-title":"Subcell Biochem"},{"key":"1757_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","volume":"19","author":"JC Burnett","year":"2012","unstructured":"Burnett JC, Rossi JJ (2012) RNA-based therapeutics: current progress and future prospects. Chem Biol 19:60\u201371. https:\/\/doi.org\/10.1016\/j.chembiol.2011.12.008","journal-title":"Chem Biol"},{"key":"1757_CR8","doi-asserted-by":"publisher","first-page":"8226","DOI":"10.1080\/21655979.2022.2049470","volume":"13","author":"L Cai","year":"2022","unstructured":"Cai L, Hu X, Ye L, Bai P, Jie Y, Shu K (2022) Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by targeting microRNA-587\/solute carrier family 7 member 11 axis in epithelial ovarian cancer. Bioengineered 13:8226\u20138239. https:\/\/doi.org\/10.1080\/21655979.2022.2049470","journal-title":"Bioengineered"},{"key":"1757_CR9","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","volume":"83","author":"K Chang","year":"2023","unstructured":"Chang K, Chen Y, Zhang X, Zhang W, Xu N, Zeng B, Wang Y, Feng T, Dai B, Xu F, Ye D, Wang C (2023) DPP9 stabilizes NRF2 to suppress ferroptosis and induce Sorafenib resistance in clear cell renal cell carcinoma. Cancer Res 83:3940\u20133955. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-4001","journal-title":"Cancer Res"},{"key":"1757_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00761-9","volume":"14","author":"F Chen","year":"2023","unstructured":"Chen F, Wang L (2023) Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells. Discov Oncol 14:145. https:\/\/doi.org\/10.1007\/s12672-023-00761-9","journal-title":"Discov Oncol"},{"key":"1757_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","volume":"68","author":"D Chen","year":"2017","unstructured":"Chen D, Tavana O, Chu B, Erber L, Chen Y, Baer R, Gu W (2017) NRF2 is a major target of ARF in p53-Independent tumor suppression. Mol Cell 68:224\u2013232e224. https:\/\/doi.org\/10.1016\/j.molcel.2017.09.009","journal-title":"Mol Cell"},{"key":"1757_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D (2020) Iron metabolism in ferroptosis. Front Cell Dev Biol 8:590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226","journal-title":"Front Cell Dev Biol"},{"key":"1757_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.omtn.2021.08.032","volume":"26","author":"L Chen","year":"2021","unstructured":"Chen L, Li W, Li Z, Song Y, Zhao J, Chen Z, Kazobinka G, Li L, Xing Y, Hou T (2021) CircNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p\/MDM2\/p53 axis. Mol Ther 26:625\u2013636. https:\/\/doi.org\/10.1016\/j.omtn.2021.08.032","journal-title":"Mol Ther"},{"key":"1757_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2223377","volume":"24","author":"H Chen","year":"2023","unstructured":"Chen H, Wang L, Liu J, Wan Z, Zhou L, Liao H, Wan R (2023a) LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2\/NAMPT axis. Cancer Biol Ther 24:2223377. https:\/\/doi.org\/10.1080\/15384047.2023.2223377","journal-title":"Cancer Biol Ther"},{"key":"1757_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang W, Abdul Razak SR, Han T, Ahmad NH, Li X (2023b) Ferroptosis as a potential target for cancer therapy. Cell Death Dis 14:460. https:\/\/doi.org\/10.1038\/s41419-023-05930-w","journal-title":"Cell Death Dis"},{"key":"1757_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/md22080375","author":"J Chen","year":"2024","unstructured":"Chen J, Li X, Tao J, Luo L (2024) Identification of marine-derived SLC7A11 inhibitors: molecular docking, structure-based virtual screening, cytotoxicity prediction, and molecular dynamics simulation. Mar Drugs. https:\/\/doi.org\/10.3390\/md22080375","journal-title":"Mar Drugs"},{"key":"1757_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83276-9","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhao T, Chen H, Chen J, Han W (2025) RNA binding protein ALYREF regulates ferroptosis to facilitate LUAD growth and metastasis via promoting SLC7A11 mRNA stability. Sci Rep 15:1351. https:\/\/doi.org\/10.1038\/s41598-024-83276-9","journal-title":"Sci Rep"},{"key":"1757_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144","journal-title":"Annu Rev Pathol"},{"key":"1757_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, Remiao F, Silva R (2023) Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther 244:108373. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108373","journal-title":"Pharmacol Ther"},{"key":"1757_CR20","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034366. https:\/\/doi.org\/10.1177\/20503121211034366","journal-title":"SAGE Open Med"},{"key":"1757_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.626764","volume":"12","author":"R Deng","year":"2021","unstructured":"Deng R, Cui X, Dong Y, Tang Y, Tao X, Wang S, Wang J, Chen L (2021) Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of hepatocellular carcinoma. Front Genet 12:626764. https:\/\/doi.org\/10.3389\/fgene.2021.626764","journal-title":"Front Genet"},{"issue":"2","key":"1757_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00011-022-01672-1","volume":"72","author":"L Deng","year":"2023","unstructured":"Deng L, He S, Guo N, Tian W, Zhang W, Luo L (2023) Molecular mechanisms of ferroptosis and relevance to inflammation. Inflamm Res 72(2):281\u2013299. https:\/\/doi.org\/10.1007\/s00011-022-01672-1","journal-title":"Inflamm Res"},{"key":"1757_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1593096","volume":"13","author":"F Ding","year":"2025","unstructured":"Ding F, Yu Y, Zhao J, Wei S, Zhang Y, Han JH, Li Z, Jiang HB, Ryu D, Cho M, Bae SJ, Park W, Ha KT, Gao B (2025) The interplay of cellular senescence and reprogramming shapes the biological landscape of aging and cancer revealing novel therapeutic avenues. Front Cell Dev Biol 13:1593096. https:\/\/doi.org\/10.3389\/fcell.2025.1593096","journal-title":"Front Cell Dev Biol"},{"key":"1757_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"1757_CR25","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","volume":"28","author":"LA Donehower","year":"2019","unstructured":"Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, Li X, Babur O, Hsu TK, Lichtarge O, Weinstein JN, Akbani R, Wheeler DA (2019) Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas. Cell Rep 28:1370\u20131384e1375. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.001","journal-title":"Cell Rep"},{"key":"1757_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0181-6","volume":"9","author":"X Dong","year":"2018","unstructured":"Dong X, Hu X, Chen J, Hu D, Chen LF (2018) BRD4 regulates cellular senescence in gastric cancer cells via E2F\/miR-106b\/p21 axis. Cell Death Dis 9:203. https:\/\/doi.org\/10.1038\/s41419-017-0181-6","journal-title":"Cell Death Dis"},{"key":"1757_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02101-2","volume":"8","author":"E Dornier","year":"2017","unstructured":"Dornier E, Rabas N, Mitchell L, Novo D, Dhayade S, Marco S, Mackay G, Sumpton D, Pallares M, Nixon C, Blyth K, Macpherson IR, Rainero E, Norman JC (2017) Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells. Nat Commun 8:2255. https:\/\/doi.org\/10.1038\/s41467-017-02101-2","journal-title":"Nat Commun"},{"key":"1757_CR28","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.7150\/jca.96608","volume":"15","author":"WL Duan","year":"2024","unstructured":"Duan WL, Wang XJ, Guo A, Gu LH, Sheng ZM, Luo H, Yang LX, Wang WH, Zhang BG (2024) Mir-141-3p promotes Paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. J Cancer 15:5622\u20135635. https:\/\/doi.org\/10.7150\/jca.96608","journal-title":"J Cancer"},{"key":"1757_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104907","volume":"214","author":"M Ebrahimnezhad","year":"2025","unstructured":"Ebrahimnezhad M, Valizadeh A, Yousefi B (2025) Ferroptosis and immunotherapy: breaking barriers in cancer treatment resistance. Crit Rev Oncol Hematol 214:104907. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104907","journal-title":"Crit Rev Oncol Hematol"},{"key":"1757_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.65","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N (2017) Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis 6:e371. https:\/\/doi.org\/10.1038\/oncsis.2017.65","journal-title":"Oncogenesis"},{"key":"1757_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03042-7","volume":"19","author":"L Feng","year":"2021","unstructured":"Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, Li B (2021) Slc7a11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med 19:367. https:\/\/doi.org\/10.1186\/s12967-021-03042-7","journal-title":"J Transl Med"},{"key":"1757_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116345","volume":"226","author":"R Fu","year":"2024","unstructured":"Fu R, You Y, Wang Y, Wang J, Lu Y, Gao R, Pang M, Yang P, Wang H (2024) Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p\/MDM2\/p53 signaling pathway. Biochem Pharmacol 226:116345. https:\/\/doi.org\/10.1016\/j.bcp.2024.116345","journal-title":"Biochem Pharmacol"},{"key":"1757_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s13770-021-00346-z","volume":"18","author":"S Go","year":"2021","unstructured":"Go S, Kang M, Kwon SP, Jung M, Jeon OH, Kim BS (2021) The senolytic drug JQ1 removes senescent cells via ferroptosis. Tissue Eng Regen Med 18:841\u2013850. https:\/\/doi.org\/10.1007\/s13770-021-00346-z","journal-title":"Tissue Eng Regen Med"},{"key":"1757_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05966-y","volume":"14","author":"W Guo","year":"2023","unstructured":"Guo W, Wang X, Lu B, Yu J, Xu M, Huang R, Cheng M, Yang M, Zhao W, Zou C (2023) Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma. Cell Death Dis 14:439. https:\/\/doi.org\/10.1038\/s41419-023-05966-y","journal-title":"Cell Death Dis"},{"key":"1757_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05192-y","volume":"13","author":"Y Han","year":"2022","unstructured":"Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W, Liu H, Chu Y, Cao J, Jiang M, Yang S, Shi Y, Xie X, Chen F, Han Y, Qin W, Xu B, Liang J (2022) Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death Dis 13:742. https:\/\/doi.org\/10.1038\/s41419-022-05192-y","journal-title":"Cell Death Dis"},{"key":"1757_CR36","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/hep.32062","volume":"74","author":"Q He","year":"2021","unstructured":"He Q, Liu M, Huang W, Chen X, Zhang B, Zhang T, Wang Y, Liu D, Xie M, Ji X, Sun M, Tian D, Xia L (2021) IL-1beta-Induced elevation of solute carrier family 7 member 11 promotes hepatocellular carcinoma metastasis through Up-regulating programmed death ligand 1 and Colony-Stimulating factor 1. Hepatology 74:3174\u20133193. https:\/\/doi.org\/10.1002\/hep.32062","journal-title":"Hepatology"},{"key":"1757_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115241","volume":"205","author":"J He","year":"2022","unstructured":"He J, Wang X, Chen K, Zhang M, Wang J (2022) The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. Biochem Pharmacol 205:115241. https:\/\/doi.org\/10.1016\/j.bcp.2022.115241","journal-title":"Biochem Pharmacol"},{"key":"1757_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02022-5","volume":"40","author":"P Hernandez-Camarero","year":"2021","unstructured":"Hernandez-Camarero P, Lopez-Ruiz E, Marchal JA, Peran M (2021) Cancer: a mirrored room between tumor bulk and tumor microenvironment. J Exp Clin Cancer Res 40:217. https:\/\/doi.org\/10.1186\/s13046-021-02022-5","journal-title":"J Exp Clin Cancer Res"},{"key":"1757_CR39","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.047662","author":"M Hill","year":"2021","unstructured":"Hill M, Tran N (2021) MiRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.047662","journal-title":"Dis Model Mech"},{"key":"1757_CR40","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, Shin S, Becerra CR, Falchook G, Stoudemire J, Martin D, Kelnar K, Peltier H, Bonato V, Bader AG, Smith S, Kim S, O\u2019Neill V, Beg MS (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122:1630\u20131637. https:\/\/doi.org\/10.1038\/s41416-020-0802-1","journal-title":"Br J Cancer"},{"key":"1757_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ (2020a) Therapeutic sirna: state of the art. Signal Transduct Target Ther 5:101. https:\/\/doi.org\/10.1038\/s41392-020-0207-x","journal-title":"Signal Transduct Target Ther"},{"key":"1757_CR42","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI124049","volume":"130","author":"K Hu","year":"2020","unstructured":"Hu K, Li K, Lv J, Feng J, Chen J, Wu H, Cheng F, Jiang W, Wang J, Pei H, Chiao PJ, Cai Z, Chen Y, Liu M, Pang X (2020b) Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. J Clin Invest 130:1752\u20131766. https:\/\/doi.org\/10.1172\/JCI124049","journal-title":"J Clin Invest"},{"key":"1757_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6439097","volume":"2022","author":"M Huang","year":"2022","unstructured":"Huang M, Wu Q, Jiang ZH (2022) Epigenetic alterations under oxidative stress in stem cells. Oxid Med Cell Longev 2022:6439097. https:\/\/doi.org\/10.1155\/2022\/6439097","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1757_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113737","volume":"431","author":"X Huang","year":"2023","unstructured":"Huang X, Wu J, Wang Y, Xian Z, Li J, Qiu N, Li H (2023) FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643\/miR-153\/SLC7A11 axis. Exp Cell Res 431(1):113737. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113737","journal-title":"Exp Cell Res"},{"key":"1757_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01255-3","volume":"8","author":"T Ishii","year":"2022","unstructured":"Ishii T, Mimura I, Nagaoka K, Naito A, Sugasawa T, Kuroda R, Yamada D, Kanki Y, Kume H, Ushiku T, Kakimi K, Tanaka T, Nangaku M (2022) Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression. Cell Death Discov 8:480. https:\/\/doi.org\/10.1038\/s41420-022-01255-3","journal-title":"Cell Death Discov"},{"key":"1757_CR46","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1261\/rna.25706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L, Linsley PS (2006) Widespread siRNA off-target transcript silencing mediated by seed region sequence complementarity. RNA 12:1179\u20131187. https:\/\/doi.org\/10.1261\/rna.25706","journal-title":"RNA"},{"key":"1757_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050733","author":"A Jehl","year":"2023","unstructured":"Jehl A, Conrad O, Burgy M, Foppolo S, Vauchelles R, Ronzani C, Etienne-Selloum N, Chenard MP, Danic A, Dourlhes T, Thibault C, Schultz P, Dontenwill M, Martin S (2023) Blocking EREG\/GPX4 sensitizes head and neck cancer to cetuximab through ferroptosis induction. Cells. https:\/\/doi.org\/10.3390\/cells12050733","journal-title":"Cells"},{"key":"1757_CR48","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","volume":"37","author":"X Ji","year":"2018","unstructured":"Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y, Harris BK, Hoeksema MD, Trenary IA, Heidi C, Eisenberg R, Rathmell JC, Young JD, Massion PP (2018) xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene 37:5007\u20135019. https:\/\/doi.org\/10.1038\/s41388-018-0307-z","journal-title":"Oncogene"},{"key":"1757_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438807","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Sun M (2024) SLC7A11: the Achilles heel of tumor? Front Immunol 15:1438807. https:\/\/doi.org\/10.3389\/fimmu.2024.1438807","journal-title":"Front Immunol"},{"key":"1757_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520:57\u201362. https:\/\/doi.org\/10.1038\/nature14344","journal-title":"Nature"},{"key":"1757_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.862015","volume":"12","author":"X Jiang","year":"2022","unstructured":"Jiang X, Guo S, Xu M, Ma B, Liu R, Xu Y, Zhang Y (2022) TFAP2C-mediated lncRNA PCAT1 inhibits ferroptosis in Docetaxel-resistant prostate cancer through c-Myc\/miR-25-3p\/SLC7A11 signaling. Front Oncol 12:862015. https:\/\/doi.org\/10.3389\/fonc.2022.862015","journal-title":"Front Oncol"},{"key":"1757_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, Zhang J, Chen C, Zou X, Jiang X, Dai Y, Chen W, Qiu Y, Bo Z (2023a) Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer 22:113. https:\/\/doi.org\/10.1186\/s12943-023-01804-z","journal-title":"Mol Cancer"},{"key":"1757_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154646","volume":"248","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Cui J, Cui M, Jing R (2023b) SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K\/AKT pathway. Pathol Res Pract 248:154646. https:\/\/doi.org\/10.1016\/j.prp.2023.154646","journal-title":"Pathol Res Pract"},{"key":"1757_CR54","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073324077240624094140","author":"H Jiang","year":"2024","unstructured":"Jiang H, Zhang H, Jiang S (2024) CircDUSP22 attenuates the ferroptosis of prostate cancer cells via miR-18a-5p\/SLC7A11\/GPX4 signaling. Comb Chem High Throughput Screen. https:\/\/doi.org\/10.2174\/0113862073324077240624094140","journal-title":"Comb Chem High Throughput Screen"},{"key":"1757_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01292-4","volume":"24","author":"D Jin","year":"2024","unstructured":"Jin D, Hui Y, Liu D, Li N, Leng J, Wang G, Wang Q, Lu Z (2024) LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3\/SLC7A11 in hepatocellular carcinoma. Funct Integr Genomics 24:29. https:\/\/doi.org\/10.1007\/s10142-024-01292-4","journal-title":"Funct Integr Genomics"},{"key":"1757_CR56","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1093\/nar\/gkn342","volume":"36","author":"R Juliano","year":"2008","unstructured":"Juliano R, Alam MR, Dixit V, Kang H (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 36:4158\u20134171. https:\/\/doi.org\/10.1093\/nar\/gkn342","journal-title":"Nucleic Acids Res"},{"key":"1757_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE (2022) The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol 12:858462. https:\/\/doi.org\/10.3389\/fonc.2022.858462","journal-title":"Front Oncol"},{"key":"1757_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194968","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille N, Latunde-Dada GO (2019) Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20194968","journal-title":"Int J Mol Sci"},{"key":"1757_CR59","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","volume":"348","author":"M Kim","year":"2022","unstructured":"Kim M, Lee JS, Kim W, Lee JH, Jun BH, Kim KS, Kim DE (2022) Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression. J Control Release 348:893\u2013910. https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.039","journal-title":"J Control Release"},{"key":"1757_CR60","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1074\/jbc.M117.798405","volume":"292","author":"P Koppula","year":"2017","unstructured":"Koppula P, Zhang Y, Shi J, Li W, Gan B (2017) The glutamate\/cystine antiporter SLC7A11\/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem 292:14240\u201314249. https:\/\/doi.org\/10.1074\/jbc.M117.798405","journal-title":"J Biol Chem"},{"key":"1757_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, Gan B (2018) Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun 38:12. https:\/\/doi.org\/10.1186\/s40880-018-0288-x","journal-title":"Cancer Commun"},{"key":"1757_CR62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12:599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein Cell"},{"key":"1757_CR63","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, Hansen TB, Veno MT, Kjems J (2018) Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37:555\u2013565. https:\/\/doi.org\/10.1038\/onc.2017.361","journal-title":"Oncogene"},{"key":"1757_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"CL Kuo","year":"2022","unstructured":"Kuo CL, Ponneri Babuharisankar A, Lin YC, Lien HW, Lo YK, Chou HY, Tangeda V, Cheng LC, Cheng AN, Lee AY (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci 29:74. https:\/\/doi.org\/10.1186\/s12929-022-00859-2","journal-title":"J Biomed Sci"},{"key":"1757_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G, Hinz M, Kaul D, Habbel P, Kalin R, Franzoni E, Rybak A, Nguyen D, Veh R, Ninnemann O, Peters O, Nitsch R, Heppner FL, Golenbock D, Schott E, Ploegh HL, Wulczyn FG, Lehnardt S (2012) An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15:827\u2013835. https:\/\/doi.org\/10.1038\/nn.3113","journal-title":"Nat Neurosci"},{"key":"1757_CR66","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H, Gan B (2020) The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res 30:146\u2013162. https:\/\/doi.org\/10.1038\/s41422-019-0263-3","journal-title":"Cell Res"},{"key":"1757_CR67","doi-asserted-by":"publisher","first-page":"21603","DOI":"10.18632\/oncotarget.4269","volume":"6","author":"C Li","year":"2015","unstructured":"Li C, Liu Z, Yang F, Liu W, Wang D, Dong E, Wang Y, Wu CI, Lu X (2015) Sirnas with decreased off-target effect facilitate the identification of essential genes in cancer cells. Oncotarget 6:21603\u201321613. https:\/\/doi.org\/10.18632\/oncotarget.4269","journal-title":"Oncotarget"},{"key":"1757_CR68","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4894","author":"X Li","year":"2021","unstructured":"Li X, Si W, Li Z, Tian Y, Liu X, Ye S, Huang Z, Ji Y, Zhao C, Hao X, Chen D, Zhu M (2021a) MiR\u2013335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson\u2019s disease. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2021.4894","journal-title":"Int J Mol Med"},{"key":"1757_CR69","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun C, Qin Z (2021b) Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics 11:8322\u20138336. https:\/\/doi.org\/10.7150\/thno.62378","journal-title":"Theranostics"},{"key":"1757_CR70","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221077803","volume":"21","author":"YZ Li","year":"2022","unstructured":"Li YZ, Zhu HC, Du Y, Zhao HC, Wang L (2022) Silencing lncRNA SLC16A1-AS1 induced ferroptosis in renal cell carcinoma through miR-143-3p\/SLC7A11 signaling. Technol Cancer Res Treat 21:15330338221077803. https:\/\/doi.org\/10.1177\/15330338221077803","journal-title":"Technol Cancer Res Treat"},{"key":"1757_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1744102","volume":"2023","author":"H Li","year":"2023","unstructured":"Li H, Wei Y, Wang J, Yao J, Zhang C, Yu C, Tang Y, Zhu D, Yang J, Zhou J (2023a) Long noncoding RNA LINC00578 inhibits ferroptosis in pancreatic cancer via regulating SLC7A11 ubiquitination. Oxid Med Cell Longev 2023:1744102. https:\/\/doi.org\/10.1155\/2023\/1744102","journal-title":"Oxid Med Cell Longev"},{"key":"1757_CR72","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41417-022-00581-z","volume":"30","author":"L Li","year":"2023","unstructured":"Li L, Zhang Y, Gao Y, Hu Y, Wang R, Wang S, Li Y, He Y, Yuan C (2023b) LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 \/SLC7A11 axis in osteosarcoma cells. Cancer Gene Ther 30:704\u2013715. https:\/\/doi.org\/10.1038\/s41417-022-00581-z","journal-title":"Cancer Gene Ther"},{"key":"1757_CR73","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/tox.23670","volume":"38","author":"Q Li","year":"2023","unstructured":"Li Q, Li K, Guo Q, Yang T (2023c) Circrna circstil inhibits ferroptosis in colorectal cancer via miR-431\/SLC7A11 axis. Environ Toxicol 38:981\u2013989. https:\/\/doi.org\/10.1002\/tox.23670","journal-title":"Environ Toxicol"},{"key":"1757_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02567-z","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Yang W, Zheng Y, Dai W, Ji J, Wu L, Cheng Z, Zhang J, Li J, Xu X, Wu J, Yang M, Feng J, Guo C (2023d) Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to Sorafenib via ferroptosis. J Exp Clin Cancer Res 42:6. https:\/\/doi.org\/10.1186\/s13046-022-02567-z","journal-title":"J Exp Clin Cancer Res"},{"key":"1757_CR75","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2217\/epi-2023-0100","volume":"16","author":"J Li","year":"2024","unstructured":"Li J, Li PT, Wu W, Ding BN, Wen YG, Cai HL, Liu SX, Hong T, Zhang JF, Zhou JD, Qian LY, Du J (2024) POU2F2-mediated upregulation of LncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p\/SLC7A11 axis. Epigenomics 16:215\u2013231. https:\/\/doi.org\/10.2217\/epi-2023-0100","journal-title":"Epigenomics"},{"key":"1757_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1578927","volume":"15","author":"M Li","year":"2025","unstructured":"Li M, Dai L, Chen S, Deng M, Wang L, Sun Y (2025a) Molecular pigeon network of lncRNA and mirna: decoding metabolic reprogramming in patients with lung cancer. Front Oncol 15:1578927. https:\/\/doi.org\/10.3389\/fonc.2025.1578927","journal-title":"Front Oncol"},{"key":"1757_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144742","volume":"317","author":"W Li","year":"2025","unstructured":"Li W, Liang L, Liu S, Zeng F, Cao J, Lei Y, Yuan X, He Q, Zhou Y (2025b) CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein. Int J Biol Macromol 317:144742. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144742","journal-title":"Int J Biol Macromol"},{"key":"1757_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105807","volume":"156","author":"B Liang","year":"2023","unstructured":"Liang B, Wu Y (2023) Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11. Arch Oral Biol 156:105807. https:\/\/doi.org\/10.1016\/j.archoralbio.2023.105807","journal-title":"Arch Oral Biol"},{"key":"1757_CR79","doi-asserted-by":"publisher","first-page":"9433","DOI":"10.1073\/pnas.1821323116","volume":"116","author":"JKM Lim","year":"2019","unstructured":"Lim JKM, Delaidelli A, Minaker SW, Zhang HF, Colovic M, Yang H, Negri GL, von Karstedt S, Lockwood WW, Schaffer P, Leprivier G, Sorensen PH (2019) Cystine\/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc Natl Acad Sci USA 116:9433\u20139442. https:\/\/doi.org\/10.1073\/pnas.1821323116","journal-title":"Proc Natl Acad Sci USA"},{"key":"1757_CR80","first-page":"3106","volume":"10","author":"W Lin","year":"2020","unstructured":"Lin W, Wang C, Liu G, Bi C, Wang X, Zhou Q, Jin H (2020) SLC7A11\/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res 10:3106\u20133126","journal-title":"Am J Cancer Res"},{"key":"1757_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35707-2","volume":"13","author":"Z Lin","year":"2022","unstructured":"Lin Z, Liu J, Long F, Kang R, Kroemer G, Tang D, Yang M (2022a) The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat Commun 13:7965. https:\/\/doi.org\/10.1038\/s41467-022-35707-2","journal-title":"Nat Commun"},{"key":"1757_CR82","doi-asserted-by":"publisher","first-page":"102312","DOI":"10.1016\/j.redox.2022.102312","volume":"52","author":"Z Lin","year":"2022","unstructured":"Lin Z, Song J, Gao Y, Huang S, Dou R, Zhong P, Huang G, Han L, Zheng J, Zhang X, Wang S, Xiong B (2022b) Hypoxia-induced HIF-1alpha\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biol 52:102312. https:\/\/doi.org\/10.1016\/j.redox.2022.102312","journal-title":"Redox Biol"},{"key":"1757_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103286","volume":"75","author":"Z Lin","year":"2024","unstructured":"Lin Z, Yang S, Qiu Q, Cui G, Zhang Y, Yao M, Li X, Chen C, Gu J, Wang T, Yin P, Sun L, Hao Y (2024) Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. Redox Biol 75:103286. https:\/\/doi.org\/10.1016\/j.redox.2024.103286","journal-title":"Redox Biol"},{"key":"1757_CR84","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-981-10-1498-7_16","volume":"927","author":"Y Liu","year":"2016","unstructured":"Liu Y, Wang J (2016) Therapeutic potentials of noncoding rnas: targeted delivery of NcRNAs in cancer cells. Adv Exp Med Biol 927:429\u2013458. https:\/\/doi.org\/10.1007\/978-981-10-1498-7_16","journal-title":"Adv Exp Med Biol"},{"key":"1757_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG (2011) The microrna miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17:211\u2013215. https:\/\/doi.org\/10.1038\/nm.2284","journal-title":"Nat Med"},{"key":"1757_CR86","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, Zhuang L, You MJ, Fang B, Li W, Metallo CM, Poyurovsky MV, Gan B (2020) Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol 22:476\u2013486. https:\/\/doi.org\/10.1038\/s41556-020-0496-x","journal-title":"Nat Cell Biol"},{"key":"1757_CR87","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D (2022a) Signaling pathways and defense mechanisms of ferroptosis. FEBS J 289:7038\u20137050. https:\/\/doi.org\/10.1111\/febs.16059","journal-title":"FEBS J"},{"key":"1757_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.778","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, He J, Sun G, Huang N, Bian Z, Xu C, Zhang Y, Cui Z, Xu W, Sun F, Zhuang C, Man Q, Gu S (2022b) The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin Transl Med 12:e778. https:\/\/doi.org\/10.1002\/ctm2.778","journal-title":"Clin Transl Med"},{"key":"1757_CR89","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6459585","volume":"2022","author":"X Liu","year":"2022","unstructured":"Liu X, Hussain R, Mehmood K, Tang Z, Zhang H, Li Y (2022c) Mitochondrial-endoplasmic reticulum communication-mediated oxidative stress and autophagy. BioMed Res Int 2022:6459585. https:\/\/doi.org\/10.1155\/2022\/6459585","journal-title":"BioMed Res Int"},{"key":"1757_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03091-6","volume":"23","author":"T Liu","year":"2023","unstructured":"Liu T, Ren Y, Wang Q, Wang Y, Li Z, Sun W, Fan D, Luan Y, Gao Y, Yan Z (2023a) Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. Cancer Cell Int 23:259. https:\/\/doi.org\/10.1186\/s12935-023-03091-6","journal-title":"Cancer Cell Int"},{"key":"1757_CR91","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G, Mao C, Wu S, Zhuang L, Poyurovsky MV, James You M, Hart T, Billadeau DD, Chen J, Gan B (2023b) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25:404\u2013414. https:\/\/doi.org\/10.1038\/s41556-023-01091-2","journal-title":"Nat Cell Biol"},{"key":"1757_CR92","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/011570159X343096241209040135","volume":"23","author":"Y Liu","year":"2025","unstructured":"Liu Y, Guo Y, Zhou H, Liu Y, Jin Y, Luo K, Dou X (2025a) Modulating ferroptosis: a novel approach to promote neural repair in brain injury. Curr Neuropharmacol 23:918\u2013928. https:\/\/doi.org\/10.2174\/011570159X343096241209040135","journal-title":"Curr Neuropharmacol"},{"key":"1757_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101265","volume":"12","author":"Y Liu","year":"2025","unstructured":"Liu Y, He P, Ma X, Tian Y, Zhang Y, Wang Y, Jia Y, Liu H, Liu Y, Xu Y (2025b) The combination of SLC7A11 inhibitor and Oridonin synergistically inhibits cervical cancer cell growth by decreasing the NADPH\/NADP(+) ratio. Genes Dis 12:101265. https:\/\/doi.org\/10.1016\/j.gendis.2024.101265","journal-title":"Genes Dis"},{"key":"1757_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02787-x","volume":"30","author":"QW Lu","year":"2025","unstructured":"Lu QW, Liao Y (2025) GDF-15 upregulates the SLC7A11\/GPX4 signaling axis and promotes mitoxantrone resistance in AML cells. Eur J Med Res 30:504. https:\/\/doi.org\/10.1186\/s40001-025-02787-x","journal-title":"Eur J Med Res"},{"key":"1757_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.759346","volume":"11","author":"X Lu","year":"2021","unstructured":"Lu X, Kang N, Ling X, Pan M, Du W, Gao S (2021) MiR-27a-3p promotes non-small cell lung cancer through SLC7A11-mediated-ferroptosis. Front Oncol 11:759346. https:\/\/doi.org\/10.3389\/fonc.2021.759346","journal-title":"Front Oncol"},{"key":"1757_CR96","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5126048","volume":"2017","author":"C Luo","year":"2017","unstructured":"Luo C, Zhang H (2017) The role of proinflammatory pathways in the pathogenesis of Colitis-Associated colorectal cancer. Mediators Inflamm 2017:5126048. https:\/\/doi.org\/10.1155\/2017\/5126048","journal-title":"Mediators Inflamm"},{"key":"1757_CR97","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-997","volume":"9","author":"N Lyu","year":"2021","unstructured":"Lyu N, Zeng Y, Kong Y, Chen Q, Deng H, Ou S, Bai Y, Tang H, Wang X, Zhao M (2021) Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009\/miR-1261\/SLC7A11 axis. Ann Transl Med 9:675. https:\/\/doi.org\/10.21037\/atm-21-997","journal-title":"Ann Transl Med"},{"key":"1757_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101801","volume":"38","author":"L Ma","year":"2021","unstructured":"Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K, Xu X, Niu Y, Guo S, Zhang C, Qiu S, Qiao Y, Fang W, Du L, Yu Y, Wang J (2021) The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol 38:101801. https:\/\/doi.org\/10.1016\/j.redox.2020.101801","journal-title":"Redox Biol"},{"key":"1757_CR99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2147\/PGPM.S426205","volume":"16","author":"Y Ma","year":"2023","unstructured":"Ma Y, Gao J, Guo H (2023) Circ_0000140 alters miR-527\/SLC7A11-mediated ferroptosis to influence oral squamous cell carcinoma cell resistance to DDP. Pharmgenomics Pers Med 16:1079\u20131089. https:\/\/doi.org\/10.2147\/PGPM.S426205","journal-title":"Pharmgenomics Pers Med"},{"key":"1757_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111760","volume":"131","author":"X Ma","year":"2025","unstructured":"Ma X, Cao D, Zhang Y, Ding X, Hu Z, Wang J (2025) Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11\/GPX4\/ACSL4 axis. Cell Signal 131:111760. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111760","journal-title":"Cell Signal"},{"key":"1757_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118023","volume":"186","author":"H Mahaki","year":"2025","unstructured":"Mahaki H, Nobari S, Tanzadehpanah H, Babaeizad A, Kazemzadeh G, Mehrabzadeh M, Valipour A, Yazdinezhad N, Manoochehri H, Yang P, Sheykhhasan M (2025) Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: therapeutic strategies and insights. Biomed Pharmacother 186:118023. https:\/\/doi.org\/10.1016\/j.biopha.2025.118023","journal-title":"Biomed Pharmacother"},{"key":"1757_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174342","author":"E Martino","year":"2023","unstructured":"Martino E, Balestrieri A, Aragona F, Bifulco G, Mele L, Campanile G, Balestrieri ML, D\u2019Onofrio N (2023) Mir-148a-3p promotes colorectal cancer cell ferroptosis by targeting SLC7A11. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15174342","journal-title":"Cancers (Basel)"},{"key":"1757_CR103","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495:333\u2013338. https:\/\/doi.org\/10.1038\/nature11928","journal-title":"Nature"},{"key":"1757_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081590","author":"M Merkel","year":"2023","unstructured":"Merkel M, Goebel B, Boll M, Adhikari A, Maurer V, Steinhilber D, Culmsee C (2023) Mitochondrial reactive oxygen species formation determines ACSL4\/LPCAT2-mediated ferroptosis. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox12081590","journal-title":"Antioxidants (Basel)"},{"key":"1757_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/biology13110949","author":"N Mohamady Farouk Abdalsalam","year":"2024","unstructured":"Mohamady Farouk Abdalsalam N, Liang Z, Kashaf Tariq H, Ibrahim A, Li R, Wan X, Yan D (2024) Etomoxir sodium salt promotes imidazole ketone Erastin-induced myeloid-derived suppressor cell ferroptosis and enhances cancer therapy. Biology. https:\/\/doi.org\/10.3390\/biology13110949","journal-title":"Biology"},{"key":"1757_CR106","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/s41417-023-00648-5","volume":"30","author":"M Mu","year":"2023","unstructured":"Mu M, Zhang Q, Zhao C, Li X, Chen Z, Sun X, Yu J (2023) 3-bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis. Cancer Gene Ther 30:1414\u20131425. https:\/\/doi.org\/10.1038\/s41417-023-00648-5","journal-title":"Cancer Gene Ther"},{"key":"1757_CR107","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2291855","volume":"25","author":"P Nath","year":"2024","unstructured":"Nath P, Alfarsi LH, El-Ansari R, Masisi BK, Erkan B, Fakroun A, Ellis IO, Rakha EA, Green AR (2024) The amino acid transporter SLC7A11 expression in breast cancer. Cancer Biol Ther 25:2291855. https:\/\/doi.org\/10.1080\/15384047.2023.2291855","journal-title":"Cancer Biol Ther"},{"key":"1757_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02394-7","volume":"12","author":"H Ni","year":"2021","unstructured":"Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q, Xi T, Xing Y, Zheng L (2021) MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther 12:325. https:\/\/doi.org\/10.1186\/s13287-021-02394-7","journal-title":"Stem Cell Res Ther"},{"key":"1757_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1353787","volume":"15","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P (2024) Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy. Front Immunol 15:1353787. https:\/\/doi.org\/10.3389\/fimmu.2024.1353787","journal-title":"Front Immunol"},{"key":"1757_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.879317","volume":"13","author":"Z Nie","year":"2022","unstructured":"Nie Z, Chen M, Gao Y, Huang D, Cao H, Peng Y, Guo N, Wang F, Zhang S (2022) Ferroptosis and tumor drug resistance: current status and major challenges. Front Pharmacol 13:879317. https:\/\/doi.org\/10.3389\/fphar.2022.879317","journal-title":"Front Pharmacol"},{"key":"1757_CR111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","volume":"45","author":"L Ouyang","year":"2012","unstructured":"Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK (2012) Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 45:487\u2013498. https:\/\/doi.org\/10.1111\/j.1365-2184.2012.00845.x","journal-title":"Cell Prolif"},{"key":"1757_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175317","volume":"934","author":"C Pan","year":"2022","unstructured":"Pan C, Chen G, Zhao X, Xu X, Liu J (2022a) LncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p\/SLC7A11 axis. Eur J Pharmacol 934:175317. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175317","journal-title":"Eur J Pharmacol"},{"key":"1757_CR113","doi-asserted-by":"publisher","first-page":"366","DOI":"10.21037\/tlcr-22-138","volume":"11","author":"CF Pan","year":"2022","unstructured":"Pan CF, Wei K, Ma ZJ, He YZ, Huang JJ, Guo ZZ, Chen ZP, Barr MP, Shackelford RE, Xia Y, Wang J (2022b) CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma. Transl Lung Cancer Res 11:366\u2013380. https:\/\/doi.org\/10.21037\/tlcr-22-138","journal-title":"Transl Lung Cancer Res"},{"key":"1757_CR114","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7150\/jca.82066","volume":"14","author":"Y Peng","year":"2023","unstructured":"Peng Y, Ouyang L, Zhou Y, Lai W, Chen Y, Wang Z, Yan B, Zhang Z, Zhou Y, Peng X, Chen J, Peng X, Xiao D, Liu S, Tao Y, Liu W (2023) AhR promotes the development of non-small cell lung cancer by inducing SLC7A11-dependent antioxidant function. J Cancer 14:821\u2013834. https:\/\/doi.org\/10.7150\/jca.82066","journal-title":"J Cancer"},{"key":"1757_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7497\/j.issn.2095-3941.2014.01.001","volume":"11","author":"LM Phan","year":"2014","unstructured":"Phan LM, Yeung SC, Lee MH (2014) Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med 11:1\u201319. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2014.01.001","journal-title":"Cancer Biol Med"},{"key":"1757_CR116","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41418-018-0173-9","volume":"26","author":"B Proneth","year":"2019","unstructured":"Proneth B, Conrad M (2019) Ferroptosis and necroinflammation, a yet poorly explored link. Cell Death Differ 26:14\u201324. https:\/\/doi.org\/10.1038\/s41418-018-0173-9","journal-title":"Cell Death Differ"},{"key":"1757_CR117","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/tox.23605","volume":"37","author":"Y Qiao","year":"2022","unstructured":"Qiao Y, Wang B, Yan Y, Niu L (2022) Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p\/CDCA3 to inactivate the p53\/p21 signaling pathway. Environ Toxicol 37:2398\u20132411. https:\/\/doi.org\/10.1002\/tox.23605","journal-title":"Environ Toxicol"},{"key":"1757_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, Liu L, Liu G, Sun H, Sun M, Wang J, Li Z, Fan J, Zhang Q, Li C, Situ F, Xue J, Jia Z, Zhang C, Zhang S, Shan C (2024) Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res 43:108. https:\/\/doi.org\/10.1186\/s13046-024-03032-9","journal-title":"J Exp Clin Cancer Res"},{"key":"1757_CR119","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5483\/BMBRep.2022-0175","volume":"56","author":"K Qin","year":"2023","unstructured":"Qin K, Zhang F, Wang H, Wang N, Qiu H, Jia X, Gong S, Zhang Z (2023) CircRNA circSnx12 confers cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p\/SLC7A11 axis. BMB Rep 56:184\u2013189 10.5483\/BMBRep.2022\u2009\u2013\u20090175","journal-title":"BMB Rep"},{"key":"1757_CR120","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47\u201362. https:\/\/doi.org\/10.1038\/nrg.2015.10","journal-title":"Nat Rev Genet"},{"key":"1757_CR121","doi-asserted-by":"publisher","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34:21\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022","DOI":"10.1016\/j.ccell.2018.03.022"},{"key":"1757_CR122","doi-asserted-by":"publisher","first-page":"500","DOI":"10.20892\/j.issn.2095-3941.2023.0108","volume":"20","author":"R Rosell","year":"2023","unstructured":"Rosell R, Jain A, Codony-Servat J, Jantus-Lewintre E, Morrison B, Ginesta JB, Gonzalez-Cao M (2023) Biological insights in non-small cell lung cancer. Cancer Biol Med 20:500\u2013518. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0108","journal-title":"Cancer Biol Med"},{"key":"1757_CR123","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/ijc.33262","volume":"147","author":"M Sato","year":"2020","unstructured":"Sato M, Onuma K, Domon M, Hasegawa S, Suzuki A, Kusumi R, Hino R, Kakihara N, Kanda Y, Osaki M, Hamada J, Bannai S, Feederle R, Buday K, Angeli JPF, Proneth B, Conrad M, Okada F, Sato H (2020) Loss of the cystine\/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice. Int J Cancer 147:3224\u20133235. https:\/\/doi.org\/10.1002\/ijc.33262","journal-title":"Int J Cancer"},{"key":"1757_CR124","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/jcp.31093","volume":"238","author":"Z Shang","year":"2023","unstructured":"Shang Z, Luo Z, Wang Y, Liu Q, Xin Y, Zhang M, Li X, Zeng S, Yu L, Zhang X, Zhang Y (2023) CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy-dependent ferroptosis. J Cell Physiol 238:2407\u20132424. https:\/\/doi.org\/10.1002\/jcp.31093","journal-title":"J Cell Physiol"},{"key":"1757_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60920-y","volume":"14","author":"L Shao","year":"2024","unstructured":"Shao L, Zhu L, Su R, Yang C, Gao X, Xu Y, Wang H, Guo C, Li H (2024) Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis. Sci Rep 14:10745. https:\/\/doi.org\/10.1038\/s41598-024-60920-y","journal-title":"Sci Rep"},{"key":"1757_CR126","doi-asserted-by":"publisher","unstructured":"Sharbeen G, McCarroll JA, Akerman A, Kopecky C, Youkhana J, Kokkinos J, Holst J, Boyer C, Erkan M, Goldstein D, Timpson P, Cox TR, Pereira BA, Chitty JL, Fey SK, Najumudeen AK, Campbell AD, Sansom OJ, Ignacio RMC, Naim S, Liu J, Russia N, Lee J, Chou A, Johns A, Gill AJ, Gonzales-Aloy E, Gebski V, Guan YF, Pajic M, Turner N, Apte MV, Davis TP, Morton JP, Haghighi KS, Kasparian J, McLean BJ, Setargew YF, Phillips PA (2021) Australian pancreatic cancer genome I cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition. Cancer Res 81:3461\u20133479. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2496","DOI":"10.1158\/0008-5472.CAN-20-2496"},{"key":"1757_CR127","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.7150\/ijbs.74546","volume":"18","author":"L Shen","year":"2022","unstructured":"Shen L, Zhang J, Zheng Z, Yang F, Liu S, Wu Y, Chen Y, Xu T, Mao S, Yan Y, Li W, Zhang W, Yao X (2022) PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer. Int J Biol Sci 18:5459\u20135474. https:\/\/doi.org\/10.7150\/ijbs.74546","journal-title":"Int J Biol Sci"},{"key":"1757_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1300","volume":"13","author":"Z Shi","year":"2023","unstructured":"Shi Z, Li Z, Jin B, Ye W, Wang L, Zhang S, Zheng J, Lin Z, Chen B, Liu F, Zhang B, Ding X, Yang Z, Shan Y, Yu Z, Wang Y, Chen J, Chen Q, Roberts LR, Chen G (2023) Loss of LncRNA DUXAP8 synergistically enhanced Sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin Transl Med 13:e1300. https:\/\/doi.org\/10.1002\/ctm2.1300","journal-title":"Clin Transl Med"},{"key":"1757_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15074","volume":"8","author":"CS Shin","year":"2017","unstructured":"Shin CS, Mishra P, Watrous JD, Carelli V, D\u2019Aurelio M, Jain M, Chan DC (2017) The glutamate\/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat Commun 8:15074. https:\/\/doi.org\/10.1038\/ncomms15074","journal-title":"Nat Commun"},{"key":"1757_CR130","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1248\/bpb.b19-00546","volume":"42","author":"S Shiromizu","year":"2019","unstructured":"Shiromizu S, Yamauchi T, Kusunose N, Matsunaga N, Koyanagi S, Ohdo S (2019) Dosing time-dependent changes in the anti-tumor effect of xCT inhibitor Erastin in human breast cancer xenograft mice. Biol Pharm Bull 42:1921\u20131925. https:\/\/doi.org\/10.1248\/bpb.b19-00546","journal-title":"Biol Pharm Bull"},{"key":"1757_CR131","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM (2019) The role of non-coding RNAs in oncology. Cell 179:1033\u20131055. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017","journal-title":"Cell"},{"key":"1757_CR132","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jncc.2023.09.001","volume":"3","author":"KX Song","year":"2023","unstructured":"Song KX, Wang JX, Huang D (2023) Therapy-induced senescent tumor cells in cancer relapse. J Natl Cancer Center 3:273\u2013278. https:\/\/doi.org\/10.1016\/j.jncc.2023.09.001","journal-title":"J Natl Cancer Center"},{"key":"1757_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2024.07.075","volume":"177","author":"C Subramanian","year":"2025","unstructured":"Subramanian C, McNamara K, Croslow SW, Tan Y, Hess D, Kiseljak-Vassiliades K, Wierman ME, Sweedler JV, Cohen MS (2025) Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11\/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway. Surgery 177:108832. https:\/\/doi.org\/10.1016\/j.surg.2024.07.075","journal-title":"Surgery"},{"key":"1757_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153778","volume":"231","author":"K Sun","year":"2022","unstructured":"Sun K, Ren W, Li S, Zheng J, Huang Y, Zhi K, Gao L (2022) MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11. Pathol Res Pract 231:153778. https:\/\/doi.org\/10.1016\/j.prp.2022.153778","journal-title":"Pathol Res Pract"},{"key":"1757_CR135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3892\/ol.2021.13165","volume":"23","author":"X Tang","year":"2022","unstructured":"Tang X, Chen W, Liu H, Liu N, Chen D, Tian D, Wang J (2022) Research progress on SLC7A11 in the regulation of cystine\/cysteine metabolism in tumors. Oncol Lett 23:47. https:\/\/doi.org\/10.3892\/ol.2021.13165","journal-title":"Oncol Lett"},{"key":"1757_CR136","doi-asserted-by":"publisher","first-page":"e2203973","DOI":"10.1002\/advs.202203973","volume":"10","author":"B Tang","year":"2023","unstructured":"Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, Xu Z, Yang Y, Weng Q, Zhao Z, Chen M, Ji J (2023) Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the Anti-PD-1\/L1 response. Adv Sci (Weinh) 10:e2203973. https:\/\/doi.org\/10.1002\/advs.202203973","journal-title":"Adv Sci (Weinh)"},{"key":"1757_CR137","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of CeRNA crosstalk and competition. Nature 505:344\u2013352. https:\/\/doi.org\/10.1038\/nature12986","journal-title":"Nature"},{"key":"1757_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188491","volume":"1875","author":"S Toden","year":"2021","unstructured":"Toden S, Zumwalt TJ, Goel A (2021) Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et Biophysica Acta (BBA) 1875:188491. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188491","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1757_CR139","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63326","author":"ME Torrence","year":"2021","unstructured":"Torrence ME, MacArthur MR, Hosios AM, Valvezan AJ, Asara JM, Mitchell JR, Manning BD (2021) The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals. Elife. https:\/\/doi.org\/10.7554\/eLife.63326","journal-title":"Elife"},{"key":"1757_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03217-y","volume":"11","author":"H Wang","year":"2020","unstructured":"Wang H, Song X, Wang Y, Yin X, Liang Y, Zhang T, Xu L, Jiang F, Dong G (2020a) CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma. Cell Death Dis 11:1010. https:\/\/doi.org\/10.1038\/s41419-020-03217-y","journal-title":"Cell Death Dis"},{"key":"1757_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.589508","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu F, Fan N, Zhou C, Li D, Macvicar T, Dong Q, Bruns CJ, Zhao Y (2020b) Targeting glutaminolysis: new perspectives to understand cancer development and novel strategies for potential target therapies. Front Oncol 10:589508. https:\/\/doi.org\/10.3389\/fonc.2020.589508","journal-title":"Front Oncol"},{"key":"1757_CR142","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Cheng Y, Mao C, Liu S, Xiao D, Huang J, Tao Y (2021a) Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther 29:2185\u20132208. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.022","journal-title":"Mol Ther"},{"key":"1757_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.670031","volume":"12","author":"HH Wang","year":"2021","unstructured":"Wang HH, Ma JN, Zhan XR (2021b) Circular RNA Circ_0067934 attenuates ferroptosis of thyroid cancer cells by miR-545-3p\/SLC7A11 signaling. Front Endocrinol (Lausanne) 12:670031. https:\/\/doi.org\/10.3389\/fendo.2021.670031","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1757_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1615\/JEnvironPatholToxicolOncol.2021039371","volume":"40","author":"W Wang","year":"2021","unstructured":"Wang W, Xie Y, Malhotra A (2021c) Potential of curcumin and quercetin in modulation of premature mitochondrial senescence and related changes during lung carcinogenesis. J Environ Pathol Toxicol Oncol 40:53\u201360. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2021039371","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"1757_CR145","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","volume":"29","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen X, Liu N, Shi Y, Liu Y, Ouyang L, Tam S, Xiao D, Liu S, Wen F, Tao Y (2021d) A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol Ther 29:263\u2013274. https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.024","journal-title":"Mol Ther"},{"key":"1757_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113636","volume":"154","author":"M Wang","year":"2022","unstructured":"Wang M, Cheng H, Wu H, Liu C, Li S, Li B, Su J, Luo S, Li Q (2022a) Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma. Biomed Pharmacother 154:113636. https:\/\/doi.org\/10.1016\/j.biopha.2022.113636","journal-title":"Biomed Pharmacother"},{"key":"1757_CR147","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/tox.23509","volume":"37","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Li Q, Li X, Feng X (2022b) A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. Environ Toxicol 37:1597\u20131607. https:\/\/doi.org\/10.1002\/tox.23509","journal-title":"Environ Toxicol"},{"key":"1757_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H (2023a) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 66:100916. https:\/\/doi.org\/10.1016\/j.drup.2022.100916","journal-title":"Drug Resist Updat"},{"key":"1757_CR149","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41401-023-01062-1","volume":"44","author":"YF Wang","year":"2023","unstructured":"Wang YF, Feng JY, Zhao LN, Zhao M, Wei XF, Geng Y, Yuan HF, Hou CY, Zhang HH, Wang GW, Yang G, Zhang XD (2023b) Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-\u03baB p65-activated SLC7A11 transcription. Acta Pharmacol Sin 44:1712\u20131724. https:\/\/doi.org\/10.1038\/s41401-023-01062-1","journal-title":"Acta Pharmacol Sin"},{"key":"1757_CR150","doi-asserted-by":"publisher","first-page":"31055","DOI":"10.1021\/acsnano.4c07676","volume":"18","author":"D Wang","year":"2024","unstructured":"Wang D, Tang L, Chen M, Gong Z, Fan C, Qu H, Liu Y, Shi L, Mo Y, Wang Y, Yan Q, Chen P, Xiang B, Liao Q, Zeng Z, Li G, Jiang W, Wu SX, Xiong W (2024a) Nanocarriers targeting circular RNA ADARB1 boost radiosensitivity of nasopharyngeal carcinoma through synergically promoting ferroptosis. ACS Nano 18:31055\u201331075. https:\/\/doi.org\/10.1021\/acsnano.4c07676","journal-title":"ACS Nano"},{"key":"1757_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127976","volume":"254","author":"HH Wang","year":"2024","unstructured":"Wang HH, Fan SQ, Zhan YT, Peng SP, Wang WY (2024b) Suppression of the SLC7A11\/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma. Int J Biol Macromol 254:127976. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127976","journal-title":"Int J Biol Macromol"},{"key":"1757_CR152","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-024-09843-y","volume":"40","author":"J Wang","year":"2024","unstructured":"Wang J, Jia Q, Jiang S, Lu W, Ning H (2024c) POU6F1 promotes ferroptosis by increasing lncRNA-CASC2 transcription to regulate SOCS2\/SLC7A11 signaling in gastric cancer. Cell Biol Toxicol 40:3. https:\/\/doi.org\/10.1007\/s10565-024-09843-y","journal-title":"Cell Biol Toxicol"},{"key":"1757_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1558290","volume":"15","author":"C Wang","year":"2025","unstructured":"Wang C, Wang J, Xing F, Liu N, Wang X (2025) Synergistic effects of 5-fluorouracil in combination with salinomycin promoted ferroptosis via inhibiting SLC7A11\/GPX4 in colorectal cancer. Front Oncol 15:1558290. https:\/\/doi.org\/10.3389\/fonc.2025.1558290","journal-title":"Front Oncol"},{"key":"1757_CR154","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 20:629\u2013651. https:\/\/doi.org\/10.1038\/s41573-021-00219-z","journal-title":"Nat Rev Drug Discov"},{"key":"1757_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080771","author":"J Wu","year":"2021","unstructured":"Wu J (2021) The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11080771","journal-title":"J Pers Med"},{"key":"1757_CR156","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.18632\/aging.202518","volume":"13","author":"P Wu","year":"2021","unstructured":"Wu P, Li C, Ye DM, Yu K, Li Y, Tang H, Xu G, Yi S, Zhang Z (2021) Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375\/409-3P\/515-5p-SLC7A11 axis. Aging 13:4663\u20134673. https:\/\/doi.org\/10.18632\/aging.202518","journal-title":"Aging"},{"key":"1757_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.890605","volume":"10","author":"Y Wu","year":"2022","unstructured":"Wu Y, Hayat K, Hu Y, Yang J (2022) Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma. Front Cell Dev Biol 10:890605. https:\/\/doi.org\/10.3389\/fcell.2022.890605","journal-title":"Front Cell Dev Biol"},{"key":"1757_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110188","volume":"761","author":"H Wu","year":"2024","unstructured":"Wu H, Zou L, Jin Y, Wang G, Cho WC, Li W, Cai Y, Song G (2024) Rituximab induces ferroptosis and RSL3 overcomes rituximab resistance in diffuse large B-cell lymphoma cells. Arch Biochem Biophys 761:110188. https:\/\/doi.org\/10.1016\/j.abb.2024.110188","journal-title":"Arch Biochem Biophys"},{"key":"1757_CR159","doi-asserted-by":"publisher","first-page":"465","DOI":"10.32604\/or.2024.050835","volume":"33","author":"L Xia","year":"2025","unstructured":"Xia L, Li G, Zhou Q, Feng YU, Ma H (2025) CircRNA circ_0015278 induces ferroptosis in lung adenocarcinoma through the miR-1228\/P53 axis. Oncol Res 33:465\u2013475. https:\/\/doi.org\/10.32604\/or.2024.050835","journal-title":"Oncol Res"},{"key":"1757_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753","journal-title":"Pharmacol Ther"},{"key":"1757_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117529","volume":"180","author":"H Xiao","year":"2024","unstructured":"Xiao H, Chen C, Yuan X, Yang L, Zheng Y, Yuan J, Huang S, Liang J, Yuan S, Li M, Wang J (2024) Gingerenone A induces ferroptosis in colorectal cancer via targeting suppression of SLC7A11 signaling pathway. Biomed Pharmacother 180:117529. https:\/\/doi.org\/10.1016\/j.biopha.2024.117529","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1757_CR162","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: process and function. Cell Death Differ 23(3):369\u2013379. https:\/\/doi.org\/10.1038\/cdd.2015.158","journal-title":"Cell Death Differ"},{"key":"1757_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103362","volume":"77","author":"Z Xin","year":"2024","unstructured":"Xin Z, Hu C, Zhang C, Liu M, Li J, Sun X, Hu Y, Liu X, Wang K (2024) LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis. Redox Biol 77:103362. https:\/\/doi.org\/10.1016\/j.redox.2024.103362","journal-title":"Redox Biol"},{"key":"1757_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105450","volume":"152","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, Luo A, Zhang K, Duan X, Wang Y (2020) Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci 152:105450. https:\/\/doi.org\/10.1016\/j.ejps.2020.105450","journal-title":"Eur J Pharm Sci"},{"key":"1757_CR165","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1002\/cam4.4395","volume":"10","author":"F Xu","year":"2021","unstructured":"Xu F, Guan Y, Xue L, Zhang P, Li M, Gao M, Chong T (2021) The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: a multi-omics study. Cancer Med 10:9078\u20139096. https:\/\/doi.org\/10.1002\/cam4.4395","journal-title":"Cancer Med"},{"key":"1757_CR166","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/tau-22-663","volume":"12","author":"F Xu","year":"2023","unstructured":"Xu F, Ji S, Yang L, Li Y, Shen P (2023a) Potential upstream lncRNA-miRNA-mRNA regulatory network of the ferroptosis-related gene SLC7A11 in renal cell carcinoma. Transl Androl Urol 12:33\u201357. https:\/\/doi.org\/10.21037\/tau-22-663","journal-title":"Transl Androl Urol"},{"key":"1757_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28135145","author":"M Xu","year":"2023","unstructured":"Xu M, Han X, Xiong H, Gao Y, Xu B, Zhu G, Li J (2023b) Cancer nanomedicine: emerging strategies and therapeutic potentials. Molecules. https:\/\/doi.org\/10.3390\/molecules28135145","journal-title":"Molecules"},{"key":"1757_CR168","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2021.09.033","volume":"522","author":"P Yadav","year":"2021","unstructured":"Yadav P, Sharma P, Sundaram S, Venkatraman G, Bera AK, Karunagaran D (2021) SLC7A11\/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells. Cancer Lett 522:211\u2013224. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.033","journal-title":"Cancer Lett"},{"key":"1757_CR169","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98:1169\u20131203. https:\/\/doi.org\/10.1152\/physrev.00023.2017","journal-title":"Physiol Rev"},{"key":"1757_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, Kondiparthi L, Lei G, Horbath A, Liu X, Mao C, Wu S, Zhuang L, James You M, Poyurovsky MV, Ma L, Olszewski K, Gan B (2023) Slc7a11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun 14:3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9","journal-title":"Nat Commun"},{"key":"1757_CR171","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02483-6","volume":"41","author":"L Yan","year":"2024","unstructured":"Yan L, Hu H, Feng L, Li Z, Zheng C, Zhang J, Yin X, Li B (2024a) ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Med Oncol 41:309. https:\/\/doi.org\/10.1007\/s12032-024-02483-6","journal-title":"Med Oncol"},{"key":"1757_CR172","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03570-4","volume":"24","author":"Y Yan","year":"2024","unstructured":"Yan Y, Huang Z, Zhu Z, Wang Y, Cao X, Yang C, Jiang J, Xia S, Shen B (2024b) IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer. Cancer Cell Int 24:386. https:\/\/doi.org\/10.1186\/s12935-024-03570-4","journal-title":"Cancer Cell Int"},{"key":"1757_CR173","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jconrel.2023.03.030","volume":"357","author":"C Yang","year":"2023","unstructured":"Yang C, Chen Z, Wei M, Hu S, Cai M, Wang N, Guan Y, Li F, Ding Q, Ling D (2023) A self-amplified ferroptosis nanoagent that inhibits the tumor upstream glutathione synthesis to reverse cancer chemoresistance. J Control Release 357:20\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.030","journal-title":"J Control Release"},{"key":"1757_CR174","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","volume":"51","author":"Q Yao","year":"2019","unstructured":"Yao Q, Chen Y, Zhou X (2019) The roles of MicroRNAs in epigenetic regulation. Curr Opin Chem Biol 51:11\u201317. https:\/\/doi.org\/10.1016\/j.cbpa.2019.01.024","journal-title":"Curr Opin Chem Biol"},{"key":"1757_CR175","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/odi.14040","volume":"29","author":"Y Yu","year":"2023","unstructured":"Yu Y, MohamedAl-Sharani H, Zhang B (2023) Ezh2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC. Oral Dis 29:880\u2013891. https:\/\/doi.org\/10.1111\/odi.14040","journal-title":"Oral Dis"},{"key":"1757_CR176","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bjc.2014.593","volume":"112","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Dai J, Deng H, Wan H, Liu M, Wang J, Li S, Li X, Tang H (2015) MiR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop. Br J Cancer 112:365\u2013374. https:\/\/doi.org\/10.1038\/bjc.2014.593","journal-title":"Br J Cancer"},{"key":"1757_CR177","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, Uchida K, O\u2019Connor OA, Stockwell BR (2019) Imidazole ketone Erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol 26:623\u2013633e629. https:\/\/doi.org\/10.1016\/j.chembiol.2019.01.008","journal-title":"Cell Chem Biol"},{"issue":"1","key":"1757_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03416-1","volume":"12","author":"HT Zhang","year":"2021","unstructured":"Zhang HT, Gui T, Liu RX, Tong KL, Wu CJ, Li Z, Huang X, Xu QT, Yang J, Tang W, Sang Y, Liu W, Liu N, Ross RD, He QY, Zha ZG (2021a) Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1. Cell Death Dis 12(1):121. https:\/\/doi.org\/10.1038\/s41419-021-03416-1","journal-title":"Cell Death Dis"},{"key":"1757_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.112376","volume":"220","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Guo S, Wang S, Li X, Hou D, Li H, Wang L, Xu Y, Ma B, Wang H, Jiang X (2021b) LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p\/SLC7A11 signaling. Ecotoxicol Environ Saf 220:112376. https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112376","journal-title":"Ecotoxicol Environ Saf"},{"key":"1757_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, Lei G, Mao C, Koppula P, Cheng W, Zhang J, Xiao Z, Zhuang L, Fang B, Chen J, Qian SB, Gan B (2021c) MTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun 12:1589. https:\/\/doi.org\/10.1038\/s41467-021-21841-w","journal-title":"Nat Commun"},{"key":"1757_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05173-1","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Bao W, Zhang S, Chen B, Zhou X, Zhao J, Shi Z, Zhang T, Chen Z, Wang L, Zheng X, Chen G, Wang Y (2022a) LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination. Cell Death Dis 13:734. https:\/\/doi.org\/10.1038\/s41419-022-05173-1","journal-title":"Cell Death Dis"},{"key":"1757_CR182","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R (2022b) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21:47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y","journal-title":"Mol Cancer"},{"key":"1757_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102493","volume":"57","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen S, Wei S, Cheng S, Shi R, Zhao R, Zhang W, Zhang Q, Hua T, Feng D, Yu Z, Wang H (2022c) CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biol 57:102493. https:\/\/doi.org\/10.1016\/j.redox.2022.102493","journal-title":"Redox Biol"},{"key":"1757_CR184","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.7150\/jca.65017","volume":"13","author":"N Zhang","year":"2022","unstructured":"Zhang N, Huang J, Xu M, Wang Y (2022d) LncRNA T-UCR Uc.339\/miR-339\/SLC7A11 axis regulates the metastasis of ferroptosis-induced lung adenocarcinoma. J Cancer 13:1945\u20131957. https:\/\/doi.org\/10.7150\/jca.65017","journal-title":"J Cancer"},{"key":"1757_CR185","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Luo M, Cui X, O\u2019Connell D, Yang Y (2022) Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a CeRNA. Cell Death Differ 29:1850\u20131863. https:\/\/doi.org\/10.1038\/s41418-022-00970-9","journal-title":"Cell Death Differ"},{"issue":"5","key":"1757_CR186","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ajps.2022.07.006","volume":"17","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Ji Y, Hu N, Yu Q, Zhang X, Li J, Wu F, Xu H, Tang Q, Li X (2022f) Ferroptosis-induced anticancer effect of Resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci 17(5):751\u2013766. https:\/\/doi.org\/10.1016\/j.ajps.2022.07.006","journal-title":"Asian J Pharm Sci"},{"key":"1757_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04136-0","volume":"21","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zheng X, Ying X, Xie W, Yin Y, Wang X (2023) CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer. J Transl Med 21:334. https:\/\/doi.org\/10.1186\/s12967-023-04136-0","journal-title":"J Transl Med"},{"key":"1757_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z (2024a) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512","journal-title":"Biomed Pharmacother"},{"key":"1757_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176943","volume":"983","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao S, Zeng F, Pan D, Cai L, Zhou Y, Wang H, Qin G, Zhang C, Chen W (2024b) Dihydroartemisinin enhances the radiosensitivity of breast cancer by targeting ferroptosis signaling pathway through hsa_circ_0001610. Eur J Pharmacol 983:176943. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176943","journal-title":"Eur J Pharmacol"},{"key":"1757_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1644","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zou L, Li X, Guo L, Hu B, Ye H, Liu Y (2024c) SLC40A1 in iron metabolism, ferroptosis, and disease: a review. WIREs Mech Dis 16:e1644. https:\/\/doi.org\/10.1002\/wsbm.1644","journal-title":"WIREs Mech Dis"},{"key":"1757_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02224-3","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yao R, Li M, Fang C, Feng K, Chen X, Wang J, Luo R, Shi H, Chen X, Zhao X, Huang H, Liu S, Yin B, Zhong C (2025) Circttc13 promotes Sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis. Mol Cancer 24:32. https:\/\/doi.org\/10.1186\/s12943-024-02224-3","journal-title":"Mol Cancer"},{"key":"1757_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.816432","volume":"13","author":"MY Zhao","year":"2022","unstructured":"Zhao MY, Liu P, Sun C, Pei LJ, Huang YG (2022) Propofol augments Paclitaxel-induced cervical cancer cell ferroptosis in vitro. Front Pharmacol 13:816432. https:\/\/doi.org\/10.3389\/fphar.2022.816432","journal-title":"Front Pharmacol"},{"key":"1757_CR193","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14715\/cmb\/2023.69.12.29","volume":"69","author":"G Zhao","year":"2023","unstructured":"Zhao G, Chen H, Luo J (2023a) CircBCAR3 sponges miR-27a-3p and mediates ferroptosis in human B-prolymphocytic leukaemia cells via SLC7A11. Cell Mol Biol (Noisy-le-grand) 69:181\u2013187. https:\/\/doi.org\/10.14715\/cmb\/2023.69.12.29","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1757_CR194","doi-asserted-by":"publisher","first-page":"C1039","DOI":"10.1152\/ajpcell.00454.2022","volume":"324","author":"J Zhao","year":"2023","unstructured":"Zhao J, Yang S, Lv C, Liu Y (2023b) Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating LncRNA DLEU1. Am J Physiol Cell Physiol 324:C1039\u2013C1052. https:\/\/doi.org\/10.1152\/ajpcell.00454.2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"1757_CR195","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.14670\/HH-18-597","volume":"38","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Cui Q, Shen J, Shen W, Weng Y (2023c) Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis. Histol Histopathol 38:1429\u20131441. https:\/\/doi.org\/10.14670\/HH-18-597","journal-title":"Histol Histopathol"},{"key":"1757_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.930654","volume":"12","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Hong X, Huang X, Jiang X, Jiang H, Huang Y, Wu W, Xue Y, Lin D (2022) Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: a bioinformatics analysis and experimental verification. Front Oncol 12:930654. https:\/\/doi.org\/10.3389\/fonc.2022.930654","journal-title":"Front Oncol"},{"key":"1757_CR197","doi-asserted-by":"publisher","first-page":"10454","DOI":"10.1080\/21655979.2022.2059958","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhao X, Wu Z, Ma Y, Li H (2022) LncRNA FLVCR1-AS1 mediates miR-23a-5p\/SLC7A11 axis to promote malignant behavior of cervical cancer cells. Bioengineered 13:10454\u201310466. https:\/\/doi.org\/10.1080\/21655979.2022.2059958","journal-title":"Bioengineered"},{"key":"1757_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G (2024a) Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9:55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5","journal-title":"Signal Transduct Target Ther"},{"key":"1757_CR199","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2320655121","volume":"121","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Yu H, Chen Y, Ren J, Lu Y, Sun Y (2024b) The CRL3(KCTD10) ubiquitin ligase-USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11. Proc Natl Acad Sci U S A 121:e2320655121. https:\/\/doi.org\/10.1073\/pnas.2320655121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1757_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70257","volume":"15","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhao Z, Jiang C, Nie C, Xiao D, Wu Z, Yu H, Zheng J, Wang X, Jiang X (2025) LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF\/USP7 axis. Clin Transl Med 15:e70257. https:\/\/doi.org\/10.1002\/ctm2.70257","journal-title":"Clin Transl Med"},{"key":"1757_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165747","volume":"1866","author":"JH Zhu","year":"2020","unstructured":"Zhu JH, De Mello RA, Yan QL, Wang JW, Chen Y, Ye QH, Wang ZJ, Tang HJ, Huang T (2020) MiR-139-5p\/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K\/Akt signaling pathway. Biochimica et Biophysica Acta (BBA) 1866:165747. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165747","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1757_CR202","doi-asserted-by":"publisher","unstructured":"Zivanovic M, Gazdic Jankovic M, Ramovic Hamzagic A, Virijevic K, Milivojevic N, Pecic K, Seklic D, Jovanovic M, Kastratovic N, Miric A, Dukic T, Petrovic I, Jurisic V, Ljujic B, Filipovic N (2023) Combined biological and numerical modeling approach for better Understanding of the cancer viability and apoptosis. Pharmaceutics 15. https:\/\/doi.org\/10.3390\/pharmaceutics15061628","DOI":"10.3390\/pharmaceutics15061628"},{"key":"1757_CR203","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12265-y","volume":"24","author":"K Zong","year":"2024","unstructured":"Zong K, Lin C, Luo K, Deng Y, Wang H, Hu J, Chen S, Li R (2024) Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3p\/SLC7A11 axis. BMC Cancer 24:496. https:\/\/doi.org\/10.1186\/s12885-024-12265-y","journal-title":"BMC Cancer"},{"key":"1757_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103460","volume":"79","author":"Q Zou","year":"2025","unstructured":"Zou Q, Zhou X, Lai J, Zhou H, Su J, Zhang Z, Zhuang X, Liu L, Yuan R, Li S, Yang S, Qu X, Feng J, Liu Y, Li Z, Huang S, Shi Z, Yan Y, Zheng Z, Ye W, Qi Q (2025) Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment. Redox Biol 79:103460. https:\/\/doi.org\/10.1016\/j.redox.2024.103460","journal-title":"Redox Biol"},{"key":"1757_CR205","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01488-3","volume":"21","author":"J Zuo","year":"2022","unstructured":"Zuo J, Zhang Z, Li M, Yang Y, Zheng B, Wang P, Huang C, Zhou S (2022) The crosstalk between reactive oxygen species and noncoding rnas: from cancer code to drug role. Mol Cancer 21:30. https:\/\/doi.org\/10.1186\/s12943-021-01488-3","journal-title":"Mol Cancer"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01757-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:07:39Z","timestamp":1769155659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01757-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":205,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01757-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"257"}}